Compound details
Hypnumbiflavonoid A
| Compound ID | CDAMM01750 |
|---|---|
| Common name | Hypnumbiflavonoid A | IUPAC name | 3,5-dihydroxy-2-(4-hydroxyphenyl)-11a-(3,5,7-trihydroxy-4-oxo-2,3-dihydrochromen-2-yl)-2,3,7a,8-tetrahydro-[1]benzofuro[2,3-h]chromene-4,9-dione |
| Molecular formula | C30H22O12 |
| Retention time | 2.28 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 575.12 | Theoretical mz | 575.118 |
| Error | 3.87 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.8334 |
| Inchi key | KKFWUGTXANEERY-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C1C=CC2(C=3C(OC2C1)=CC(O)=C4C(=O)C(O)C(OC43)C5=CC=C(O)C=C5)C6OC=7C=C(O)C=C(O)C7C(=O)C6O |
| Superclass | Phenylpropanoids and polyketides |
| Class | Flavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SEA |
| P20151 | KLK2 | Kallikrein 2 | T01908 | SEA |
| P15692 | VEGFA | Vascular endothelial growth factor A | T20761 | SEA |
| P49763 | PGF | Placenta growth factor | T70792 | SEA |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SEA |
| P16152 | CBR1 | Carbonyl reductase [NADPH] 1 | T70518 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T01908 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | P20151 | KLK2 |
| T20761 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P15692 | VEGFA |
| T20761 | DI0365 | Retinopathy | [ICD-11: 9B71] | P15692 | VEGFA |
| T20761 | DI0430 | Vascular system developmental anomaly | [ICD-11: LA90] | P15692 | VEGFA |
| T70792 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P49763 | PGF |
| T70518 | DI0037 | Asthma | [ICD-11: CA23] | P16152 | CBR1 |